Story
Swedish Stocks Close Higher as Industrial Gains Offset AstraZeneca Losses

Summary
Sweden's benchmark OMX Stockholm 30 index rose 0.45% on Thursday, lifted by strong performance from industrial and technology stocks which counteracted a significant decline in shares of AstraZeneca.
Swedish stocks ended Thursday's trading session on a positive note, with the benchmark OMX Stockholm 30 index climbing 0.45%. The advance was primarily driven by gains in the Industrials, Basic Materials, and Technology sectors, according to market data.
Market Performance
The overall market sentiment in Stockholm was positive, with advancing stocks outnumbering decliners. Data from the Stockholm Stock Exchange showed 385 companies finishing higher compared to 308 that fell, while 89 stocks remained unchanged.
Sector Leaders and Laggards
Industrial stocks were the standout performers of the day, leading the blue-chip index higher. The session's top gainers included:
- Atlas Copco AB Class A (ST:ATCOa), which rose 3.14%.
- ABB Ltd (ST:ABB), which added 2.86%.
- Epiroc AB Class A (ST:EPIRa), closing up 2.62%.
AdHowever, these gains were partially offset by significant losses in the healthcare and telecom sectors. The worst performers on the index were:
- AstraZeneca PLC (ST:AZN), which fell 3.57%.
- Telefonaktiebolaget LM Ericsson Class B (ST:ERICb), declining 3.10%.
- Evolution AB (ST:EVOG), which was down 1.86%.
Currency and Commodity Markets
In foreign exchange markets, the Swedish krona strengthened against the euro and the U.S. dollar. The EUR/SEK pair declined by 0.64% to 10.99, while the USD/SEK pair fell 1.13% to 9.53. This coincided with a broader drop in the US Dollar Index Futures, which was down 0.86%.
In commodities, crude oil prices retreated, but precious metals gained. Gold futures for August delivery rose 1.80% to $4,108.90 a troy ounce.
Read next
More on Stocks
Praxis Options See Large Bullish Bet Ahead of Two FDA Decisions
A significant options trade on Praxis Precision Medicines suggests a trader is positioning for a substantial stock move ahead of two key FDA drug approval decisions slated for late 2026 and early 2027.

General Mills Appoints COO Dana McNabb as CEO to Succeed Jeff Harmening
The consumer goods company named 27-year veteran Dana McNabb its next chief executive, effective Jan. 1, as it navigates high inflation and competition from private-label brands.

Helsinki Benchmark Index Slips on Industrial and Financial Sector Weakness
Finland's OMX Helsinki 25 index closed down 0.55% on Wednesday, dragged lower by losses in the telecommunications, industrial, and financial sectors.

BEL 20 Index Falls to One-Month Low on Sector-Wide Weakness
Belgium's benchmark BEL 20 index fell 0.73% on Wednesday, hitting a new one-month low. The decline was driven by losses in the technology, financials, and consumer goods sectors, with Warehouses de Pauw NV leading the laggards.